Head to Head Review: AMERIGROUP (AGP) vs. Its Rivals

AMERIGROUP (NYSE: AGP) is one of 15 publicly-traded companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it weigh in compared to its peers? We will compare AMERIGROUP to similar businesses based on the strength of its analyst recommendations, earnings, valuation, dividends, risk, institutional ownership and profitability.

Analyst Ratings

This is a summary of recent recommendations and price targets for AMERIGROUP and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMERIGROUP 0 0 0 0 N/A
AMERIGROUP Competitors 57 326 509 9 2.52

As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 23.81%. Given AMERIGROUP’s peers higher probable upside, analysts clearly believe AMERIGROUP has less favorable growth aspects than its peers.

Institutional & Insider Ownership

69.5% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by institutional investors. 10.8% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Volatility & Risk

AMERIGROUP has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, AMERIGROUP’s peers have a beta of 1.50, indicating that their average stock price is 50% more volatile than the S&P 500.

Profitability

This table compares AMERIGROUP and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
AMERIGROUP N/A N/A N/A
AMERIGROUP Competitors 3.52% 3.52% 4.31%

Earnings & Valuation

This table compares AMERIGROUP and its peers gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
AMERIGROUP N/A N/A 35.82
AMERIGROUP Competitors $1.06 billion -$22.56 million 806.31

AMERIGROUP’s peers have higher revenue, but lower earnings than AMERIGROUP. AMERIGROUP is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

AMERIGROUP peers beat AMERIGROUP on 8 of the 8 factors compared.

About AMERIGROUP

AMERIGROUP Corporation is a multi-state managed healthcare company focused on serving people who receive healthcare benefits through publicly funded healthcare programs, including Medicaid, Children’s Health Insurance Program (CHIP), Medicaid expansion programs and Medicare Advantage. The Company offers a continuum of care management, including disease management, pharmacy integration, centralized telephonic case management, in-person case management within healthcare facilities, and home visit case management for some of its members. As of December 31, 2011, the Company provided a number of healthcare products to approximately 2,024,000 members. Effective February 1, 2012, it provides managed care services in Louisiana. On May 1, 2012, it acquired Health Plus. In November 2012, the Company sold its Virginia health plan to Inova Health System Foundation. In December 2012, WellPoint Inc acquired the Company.

What are top analysts saying about AMERIGROUP Co.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for AMERIGROUP Co. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit